Adverse reactions to food, expressed as food sensitivity or food intolerance, are on the rise [1] [2] [3] . This increase in prevalence cannot be explained by genetic drift, sug gesting a critical role of yet unknown environmental factors as modifiers of disease expression 4 . Studies have linked food sensitivities to a variety of microbial signals that could be induced by enteric infections or alter ations in the commensal gut microbiota 4, 5 . However, the specific mechanisms behind these associations remain unclear. In this Review, we examine two major pathways of food sensitivities, diet-microorganism and hostmicroorganism interactions, and discuss the mecha nistic evidence through which they can favour specific adverse reactions to food. Protein antigens in particular can become substrates of gut microorganism metabo lism, which can result in altered antigenicity 6 or in the production of metabolites that directly affect tolerogenic responses 7 . We also discuss treatment strategies designed to target these pathways that could be developed to prevent or better treat food sensitivities 8 .
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Adverse reactions to food
It is estimated that onefifth of the population world wide experiences adverse reactions to dietary compo nents 1 . Manifestations are diverse depending on the underlying aetiology and pathophysiological processes involved 1 ( Fig. 1) . Food intolerances involve nonimmune mechanisms, such as lactose maldigestion, in which there is an inability to break down the disaccharide lactose owing to primary or secondary deficiency of βgalactosidase (lactase). As a consequence, undigested lactose reaches the colon, where it is fermented by the gut microbiota, leading to gas production (hydrogen, carbon dioxide and methane) and bloating 9 . In other clinical entities, such as functional gastrointestinal dis orders for which food is often suspected to be a trigger, the specific food components and underlying mechanisms responsible for symptom generation remain unclear [10] [11] [12] . Some of these patients do not receive a conclusive diag nosis even following placebocontrolled food challenge. It remains uncertain whether this difficulty in reach ing a conclusive diagnosis results from insufficient laboratory diagnostics or whether such patients have central nervous systemdriven mechanisms (nocebo effect) that are not identifiable by diagnostic methods currently available 13 . Food sensitivities with allergic pathophysiology involve immunoglobulin E (IgE) mechanisms, non IgEmediated mechanisms or a combination of both (Fig. 1) . IgEmediated food allergy requires sensitization characterized by production of food allergenspecific IgE 14 . Upon reexposure to the allergen, allergenspecific IgE, which is bound to FcεRI (also known as FCER1A) on mast cells and basophils, becomes crosslinked and
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Alberto Caminero 1, 3 , Marlies Meisel 2, 3 , Bana Jabri 2 and Elena F. Verdu 1 releases mediators, such as histamine, that cause acute symptoms 14 . A strong response to the allergen could lead to anaphylaxis, which is defined as a severe allergic reaction of rapid onset affecting multiple tissues that can cause death 14 . NonIgEmediated food allergy includes different medical conditions such as proteininduced enterocolitis syndrome and food proteininduced procto colitis. Although they are classified as nonIgE mediated diseases, some studies suggest that there is mucosal IgE production but at insufficient circulat ing levels to be detected 15 . In contrast to welldefined IgEmediated food allergy, the diagnostic approaches and immune mechanisms underlying these condi tions are not well understood, although TNF has been implicated according to evidence [15] [16] [17] . Another group of chronic conditions with allergic pathophysiology and poorly understood mechanisms involving both IgE and nonIgE responses includes cow's milk protein allergy, eosinophilic oesophagitis and gastroenteritis. In eosinophilic oesophagitis and gastroenteritis, the nature of the food allergen remains undetermined 1, 14 . On the other hand, coeliac disease is a wellcharacterized CD4 + T cellmediated food sensitivity with autoimmunelike features triggered by ingestion of glutencontaining cere als in genetically predisposed individuals harbouring HLA-DQ2 and HLA-DQ8 genes 18 . In addition to coe liac disease, nonallergy, noncoeliac wheat sensitivity (NCWS) has become a common condition 19 . The preva lence of NCWS has been reported to vary from 0.6-6.0% in Western populations and up to 13% if selfreported NCWS is considered [20] [21] [22] [23] . However, the prevalence of NCWS cannot be estimated with confidence owing to the lack of biomarkers and specific diagnostics 24 . Gluten, and other components in wheat, including fructans and αamylasetrypsin inhibitors (ATIs), have been identified as potential culprits for the induction of symptoms [25] [26] [27] . For instance, ATIs engage the Tolllike receptor 4 (TLR4)-protein MD2 (also known as LY96)-CD14 complex, lead to upregulation of maturation markers and elicit release of proinflammatory cytokines that lead to inflammation 27, 28 .
As with other food sensitivities and autoimmune diseases [29] [30] [31] , the prevalence of coeliac disease is increas ing worldwide 2, 32 . Because not all people with genetic risk develop coeliac disease, and because the increase in prevalence has been too quick to be explained by genetic drift, environmental factors, such as introduction of gluten to infant diets (timing, amount and frequency), breastfeeding patterns, alterations in the gut microbiota (dysbiosis) and infections, have been suspected 4, [33] [34] [35] .
Microbial environmental factors
Several groups have reported the association of food sensitivity with practices that can affect intestinal microbiota composition such as early food behaviours, antibiotic intake or caesarean delivery [36] [37] [38] . In coeliac disease, results from prospective birth cohort stud ies have been published; however, the studies do not support a statistically significant effect of early feeding practices on coeliac disease development 39, 40 . Although the conclusions do not apply to the general population, followup analyses are beginning to raise the hypoth esis that a combination of factors might have a role. Indeed, genetic and epidemiological studies showed an association between viral and bacterial infections and the onset of coeliac disease and food allergies [41] [42] [43] [44] [45] [46] , suggesting that repeated microbial infections early in life trigger food sensitivities, particularly in individuals with more moderate genetic predisposition 34, 47, 48 . A pro spective study provided evidence that an increased fre quency of rotavirus infections, which generally affects the small intestine and leads to a transient increased intestinal permeability, predicts increased risk of coe liac disease autoimmunity in genetically predisposed individuals carrying HLA risk alleles for coeliac disease and type 1 diabetes mellitus (T1DM) 41 . Interestingly, intestinal rotavirus infection is also implicated in the autoimmunity leading to T1DM 49 . It remains to be determined whether rotavirus vaccination can prevent the onset of coeliac disease, as inconsistent findings have been reported 50, 51 . Consistent with the hypothesis that infection might have a role in coeliac disease aetiol ogy, studies identified the occurrence of small intestinal Campylobacter jejuni or adenoviral infection, as well as influenza diagnosis or hepatobiliary virus infections such as hepatitis C, to be substantive risk factors in the development of coeliac disease 43, 45, 52, 53 . Shi et al. 48 have also shown that enteric infections by helminths can act as an adjuvant for the response to dietary antigens, which has implications for allergic responses to food. It will be important to investigate the effect of microbial infections early in life, as even a transitory gastro intestinal infection in the vulnerable neonatal or infant period is potentially able to disturb the local mucosal and systemic immature immune system.
In addition to the support provided by clinical and epidemiological studies for an association between intestinal bacterial and viral infections and food sensi tivities [54] [55] [56] [57] [58] [59] [60] [61] [62] (Table 1) , the role of a dysbiotic gut micro biota has also been evoked. Indeed, several groups have reported intestinal dysbiosis in coeliac disease and food allergy [56] [57] [58] [59] [62] [63] [64] [65] . For instance, it has been shown that changes in key bacterial groups in infancy
Key points
• The mechanisms underlying the expression of food sensitivities remain unclear;
however, several studies demonstrate that gut microorganisms, along with other host predisposing factors, dictate the development of these conditions. • Gut microorganisms can degrade or modify immunogenic food antigens or allergens, increasing or reducing their immunogenicity.
• Dietary food components that are insufficiently digested by host enzymes become bacterial substrates, leading to the production of metabolites such as short-chain fatty acids, which are involved in gut homeostasis.
• one key factor in the development of food sensitivities is intestinal barrier dysfunction, which can be influenced by gut microorganisms and pathogens through different pathways.
• mucosal dendritic cells present dietary antigens to naive T helper cells, promoting their differentiation into peripheral T regulatory cells; virus-host interactions abrogate this response, inducing a pathogenic response to antigens.
• enteric parasites induce T helper 2 cell immunity and protect against food allergy; this contradiction is explained by the observation that parasites induce Il-10, which blocks type 2 immunity.
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were associated with the development of food allergy later in life. One study suggested that a specific intes tinal microbial signature with a positive correlation between the genus Clostridium sensu stricto and serumspecific IgE was able to distinguish between infants with IgEmediated food allergy and those without IgE mediation 66 . In addition, coeliac diseaseassociated dysbiosis seems to be characterized by Proteobacteria expansion and the presence of opportunistic patho gens in the proximal small intestine 67 . Animal studies have provided some mechanistic insight and support the notion that responses to different antigens or aller gens can be modulated by the microbial milieu of the intestine [68] [69] [70] [71] [72] [73] . The bulk of mechanistic evidence arises from basic studies that elucidate interactions of specific microorganisms with the antigen or allergen itself, as well as the imprinting of proinflammatory or tolerance induction in the host by microorganisms. The following sections expand on these concepts.
Microorganism-diet interactions
A study in humans demonstrated that longterm diet ary patterns constitute an important determinant of gut microbiota enterotypes 74 . Others indicated that shortterm diet alters microbial community structure 75 , gene expression 75 and metabolite production 76, 77 . Studies in animal models have linked the intake of omega3 fatty acids, and of prebiotic (galactooligosaccharides or inulin) exposure during perinatal and postweaning periods, with the induction of beneficial changes in gut microbiotaderived metabolites associated with toler ance mechanisms that decrease allergic sensitization 78, 79 . However, the exact compositional characteristics of a beneficial gut microbiota, as well as the mechanisms by which those changes prevent disease, have not been completely elucidated. Dietary food components that are neither absorbed nor metabolized by the host become bacterial substrates, which subsequently leads to the prod uction of bacterial metabolites, such as the shortchain fatty acid (SCFA) butyrate 80 (Fig. 2) . In addi tion, the gut microbiota has the capacity to modify the chemical structures of numerous dietary molecules, including allergens or antigens 6 .
Immunogenicity of food antigens. The intesti nal microbiota is considered a metabolic organ that vastly complements the host's metabolic activities 81 . One mechanism through which bacteria could affect immune responses to dietary components is through bacterial metabolism of antigens. This aspect is of parti cular relevance in coeliac disease, in which proteolytic resistant gluten proteins are the undeniable trigger of T cellmediated inflammation 82 . Gluten is a mix of proteins rich in proline and glutamine residues that confer unusual resistance to degradation by mammal ian enzymes 82 . This incomplete digestion generates, in vitro, highmolecularmass oligopeptides, which, when bound to antigenpresenting cells (APCs), are capable of activating a T cell response associated with coeliac disease 83 . These large peptides constitute attractive substrates for energy by bacteria colonizing the gastrointestinal tract. Several studies have shown that the human gastro intestinal tract, including the proximal small intestine, harbours glutendegrading bacteria such as Rothia spp. or Lactobacillus spp. that are able to utilize nondigested gluten peptides 84-88 . Caminero et al. 6 have demonstrated that, in addition to mammalian enzymes, duodenal bacteria partici pate in gluten metabolism in vivo. Indeed, depending on the type of bacteria present, the end result will be increased or reduced immunogenicity of the produced peptides 6 ( Fig. 2 ). For instance, specific opportunistic pathogens such as Pseudomonas aeruginosa further degrade digestive proteasemodified gluten peptides, NATuRe RevIews | GaStROenteROlOGy & HepatOlOGy producing shorter peptides that retain immunogenic sequences. These bacterially modified peptides trans locate through the intestinal epithelial barrier better than peptides produced by human digestive proteases, a mechanism that might facilitate the interaction of pep tides with the immune system of the host. By contrast, core members of the human duodenal microbiota such as Lactobacillus spp. can degrade and detoxify gluten peptides produced by human or opportunistic patho gen proteases 6 . Thus, there exist complex and sequen tial metabolic events in which mammalian and bacterial proteases synergize with each other to produce a diverse peptide output with variable immunogenic capacity. Interestingly, Lactobacillus spp., which predominately reside in the small intestine 89 , have been reported to be more abundant and diverse in healthy individuals than in patients with coeliac disease 57 . Further studies are required to test whether this reduced abundance of lacto bacilli in patients with coeliac disease is either caused by an ongoing (gluteninduced) inflammation and restored upon a glutenfree diet or whether restoring the presence of lactobacilli improves the gluteninduced pathophysiology. Interestingly, viral or bacterial intes tinal infection in mice could supress the abundance of certain microbial groups involved in gluten metabolism such as Lactobacillus spp., thereby affecting coeliac disease onset 90 . Modification of gluten by the intestinal microbiota is not limited to its degradation. Gluten deamidationa chemical reaction that removes an amide functional group in the amino acids asparagine or glutamineby human transglutaminase 2 (TGase2; also known as TGM2), the coeliac diseaseassociated autoantigen, is a key step in the disease process 91 . TGase2 converts glutamine residues to glutamate, which increases peptide binding affinity to HLADQ2 or HLADQ8 hetero dimers expressed on APCs that initiate the CD4 + T cellmediated inflammation characteristic of coeliac disease. In a study published in 2017, it was shown that transamidation of gluten by microbial transglutamin ase from Streptomyces mobaraensis could reduce the immuno genicity of gluten 92 . Thus, the notion is begin ning to emerge that microbial composition is a key factor in modulating the immunogenicity of dietary antigens. This aspect could apply to other food sensi tivities, as many food allergens, such as egg and peanut proteins, are resistant to degradation by mammalian proteases 93 . However, further studies are required to determine whether all allergens or antigens within a specific food (for example, the greater than ten allergens in peanut protein or the multiple immunogenic peptides described in coeliac disease) 94 could be fully degraded or metabolized by microbial ecosystems to a degree that effectively improves clinical symptoms. Thus, although questions based on colonization capacity and stability of the strains in the human gastrointestinal tract can be raised, microorganisms with the ability to degrade or modify immunogenic food antigens or allergens could be an attractive field for therapeutic development in the future.
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Metabolites with immunomodulatory function. Under steady state, the intestinal microbiota has an essential role in maintaining a tolerogenic gut environment that prevents an inflammatory response against foreign antigens, mainly by promoting epithelial integrity and tolero genic regulatory T (T reg ) cell function 95 . Many of these effects are mediated by immunomodulatory meta bolites that result from the bacterial metabolism of dietary substrates (Fig. 2) . Bacterial metabolic products such as SCFAs or tryptophanderived metabolites have been shown to directly regulate mucosal immune func tion and the intestinal barrier, affecting the predispo sition to food sensitivity 96, 97 . Specifically, alterations of these metabolites have been described in patients with food sensitivities 57, 98 . Butyrate, which is derived from the bacterial metabo lism of dietary fibre 99 , regulates both the proportions and the functional capabilities of forkhead box protein P3 (FOXP3) + T reg cells 7, 100, 101 , which are central to the main tenance of tolerance to food antigens or allergens 102, 103 . A study in mice showed that highfibre feeding reshaped gut microbial ecology and increased the release of SCFAs, improving oral tolerance to food allergens by activating retinal dehydrogenase activity in CD103 + den dritic cells (DCs) 104 . This feeding regimen also boosted IgA production and enhanced T follicular helper and mucosal germinal centre responses, regulating numer ous protective pathways in the gastrointestinal tract that are necessary for immune nonresponsiveness to food antigens 104 . The importance of bacterial metabolites in maintaining epithelial barrier integrity under tissue distress was demonstrated in a study by Fukuda et al. 105 who showed that the SCFA acetate was able to promote epithelial integrity during enteropathogenic infection in Dietary patterns constitute an important determinant of gut microbiota diversity , altering microbial community structure and metabolite production. Dietary food components that are not metabolized by the host become bacterial substrates. Products of bacterial metabolic activity , such as the short-chain fatty acids, are recognized by host receptors in dendritic cells (DCs) and epithelial cells promoting homeostasis through immune modulatory pathways and barrier protection (left side). Microorganisms can also metabolize food protein antigens through specific enzymatic activity , increasing or reducing their immunogenicity. Alteration of bacterial composition and/or the functional and metabolic capabilities of resident bacteria, as well as intestinal infections (microbial determinants), could promote T cell-mediated food sensitivities in genetically susceptible people (right side). A non-balanced diet can promote a microbiota with a lower diversity and metabolic output. The lack of bacterial metabolites could impair gut homeostasis, predisposing the host to develop food sensitivities. Dysbiosis could also lead to partially degraded food antigens, producing immunogenic peptides that translocate the mucosal barrier better than non-partially digested antigens. Once in the lamina propria, food antigens (such as gluten peptides) will be recognized by antigen-presenting cells such as DCs harbouring major histocompatibility complex (MHC) class II genes, which mediate the production of pro-inflammatory cytokines (IL-12, IL-6 and IFNγ). In the case of coeliac disease, an adaptive immune response with gluten-specific T cells and B cells producing antibodies against gluten will be generated. TCR , T cell receptor.
mice. In agreement with this finding, others showed that members of the Firmicutes phylum (such as Clostridia), through IL22 induced by bacteria, protected against allergic sensitization to food allergens by regulating innate lymphoid cell function and intestinal epithelial permeability 72 . In addition, IL15, a proinflammatory cytokine upregulated in the epithelium and the lamina propria in coeliac disease 106 , led to dysbiosis with an overall reduction of butyrate and a decreased abundance of butyrateproducing bacteria, which was associated with a higher susceptibility to intestinal inflamma tion 107 . Findings also indicate that butyrate quenches the inhibitory effects of IL12 on FOXP3 + T reg cell expan sion (B.J., unpublished observations), which was shown to be upregulated by mucosal DCs in the presence of high IL15 together with retinoic acid (RA) and shown to lead to loss of tolerance (LOT) to gluten 106 . In food allergy, dietary intervention with a butyrateproducing Lactobacillus strain for 6 months alleviated cow's milk allergy symptoms in infants and was associated with changes in the composition of the intestinal micro biota 108 . Furthermore, it was shown that Bifidobacterium spp., via production of acetate, promoted intestinal epi thelial integrity and protected against lethal infection, potentially alleviating food allergy in mice by inducing apoptosis in mast cells 105 . Another emerging example relates to the prod uction of aryl hydrocarbon receptor (AhR) ligands by microbial metabolism of dietary substrates rich in tryptophan 109 . The indole group in the amino acid tryptophan is metabolized by bacteria, such as Lactobacillus spp. or Streptococcus spp., releasing potent stimulators (3indolepropionic acid, indole3 carboxaldehyde or indole) of AhR 65, 97 . This receptor is a cytosolic liganddependent transcription factor that is highly expressed in the intestinal epithelium and other immune cells that regulate important homeostatic functions in the gut, including maintenance of barrier function and maturation of the immune system 109,110 . Activation of AhR positively affects DC phenotype and function during allergic sensitization and could lead to protection in a mouse peanut allergy model 111-113 . Although using dietary interventions and their effects on the gut microbiota to avoid food sensitivities is still far from clinical application, deciphering beneficial bac terial molecules and their dietary precursors is of high interest, as it could lead to sensible dietary guidelines in the future.
Other microbial determinants. Commensal intestinal bacteria protect the host from developing adverse food reactions. Specifically, direct modulation of peripherally derived FOXP3 + T reg (pT reg ) cell responses by commen sals has been described. For instance, Bacteroides fragilis was shown to promote IL10 production 114 and pT reg cell differentiation 115, 116 . Accordingly, germfree mice have been shown to develop more severe allergies 117 and more severe immunopathology in mouse models of gluten sensitivity 68 . Live bacteria, but also dead bacteria or bac terial components such as lipopolysaccharides present in the diet of germfree mice, can promote T reg cells 118, 119 . 
Induction of pro-inflammatory events
The default immune response to ingested dietary anti gens is both local and systemic active unresponsiveness, an essential physiological process in the small intestine referred to as oral tolerance, which protects mammals from developing food sensitivities 132, 133 . Environmental factors, such as enteric pathobionts, have the capacity to dictate the type of mucosal immune response and can shift the tolerogenic regulatory immune response towards dietary antigens into an inflammatory T helper cell response, which consequently results in LOT to that antigen. Thus, the question arises as to how microbial infections can affect molecular host signal ling pathways that are involved in the development of LOT to dietary antigens such as gluten in coeliac dis ease or in the development of other food sensitivities or allergies.
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Barrier dysfunction and innate immunity. Intestinal epithelial cells (IECs) have an important role in medi ating oral tolerance to dietary antigens or allergens by producing cytokines and/or signalling mediators that affect the cell types involved in oral tolerance, as well as in maintaining an intact epithelial barrier, which restricts access of larger, potentially immunogenic, macromolecules [134] [135] [136] . In addition, coeliac disease is characterized by a leaky intestinal barrier 137, 138 , and an increased intestinal permeability is suspected to trig ger the sensitization towards dietary antigens in food allergy 139 . Most importantly, it is suspected that fre quent microbial infections involving the intestinal tract could increase intestinal permeability 134 . Many patho gens interact with the intestinal barrier, underlining the importance of bacterial-host interactions in both health and disease. These effects might result from direct modi fication of tight junction proteins, activation of receptors in epithelial cells such as Tolllike receptors (TLRs) or different kinasemediated effects [140] [141] [142] [143] . Pathogens might alter the intestinal mucous layer by either improving mucus degradation or inhibiting the normal commen sal cues for mucus production 144 . Moreover, the intes tinal epithelium influences tolerance to microbial or food antigens and/or allergens by conditioning mucosal APCs towards either development of CD103 + tolero genic DCs, by releasing transforming growth factorβ (TGFβ) and RA 145, 146 under homeostatic conditions, or a proinflammatory T helper 1 (T H 1) cell or T H 2 cell response when barrier function is disrupted 147 . Loss of epithelial barrier function and innate immu nity is fundamental to the pathogenesis of food sensitivi ties. IECs and innate immune cells of the lamina propria express pattern recognition receptors (PRRs) that endow them with the ability to recognize microbial products or pathogenassociated molecular patterns (PAMPs). The role of PRRs in food sensitivity is complex. Detection of PAMPs enables the intestinal epithelium to activate sig nalling pathways that could lead to food sensitivities 148 . Furthermore, it has been suggested that dietary antigens can also be recognized by PRRs 149 . In this context, the previously mentioned wheat proteins, ATIs, could have an important role, particularly for coeliac disease and NCWS 27, 28 . On the other hand, TLRs, such as TLR4, are thought to be essential for the maintenance of intestinal homeostasis 150 . For instance, TLR4dependent signals pro vided by the microbiota inhibit the development of aller gic responses to food allergens according to experimental evidence 38 . There is also an association of food sensitiv ities with single nucleotide polymorphisms in microbial sensing receptors such as TLR6 or TLR9 (reFs [151] [152] [153] ). Thus, depending on the context, PRRs could have a protective or pathogenic role in the response to food antigens.
Studies have linked the role of innate lymphoid cells (ILCs) to food sensitivities [154] [155] [156] [157] [158] . ILCs are uniquely capable of responding to the gut microbiota owing to their tissue localization and rapid primary responses 159 . It has been described that commensal microorganisms promote a crosstalk between innate myeloid and lymphoid cells that leads to immune homeostasis in the intestine 160 . However, the implications of this crosstalk in food sensitivities have not been addressed. Chua et al. have shown that intestinal dysbiosis featuring abundance of Ruminococcus gnavus is associated with allergic diseases in infants through activation of group 2 ILCs (ILC2s) 161 . IL25producing intestinal epithelial tuft cells have been shown to initiate intestinal ILC2 responses to parasitic worm infection in animal models 162 . However, it is too early to make firm conclusions about the role of ILCs in food sensitivities.
T helper 1 cell-mediated immunity to food antigens.
In the absence of tissue distress, mucosal CD103 + DCs, which are at high frequency in the small intestinal lamina propria and mesenteric lymph nodes, present luminal dietary antigen to naive CD4 + T helper cells and promote their differentiation into pT reg cells via a TGFβdependent and RAdependent mechanism 163, 164 . Esterházy et al. 146 demonstrated that the mucosal interferon regulatory factor 8 (IRF8)dependent CD103 + CD11b -DC subset contains the most potent inducers of pT reg cells and oral tolerance under steady state conditions and that this sub set displays the most potent tolerogenic gene expression pattern, including high expression of genes encoding TGFβ and the RAcatalysing enzyme retinal dehydrogen ase 2 (RALDH2). The maturation and maintenance of this highly tolerogenic CD103 + DC subset are dependent on enteric environmental conditions 132 , and an alteration of RALDH2 activity is associated with impaired oral tol erance in animal models 165 . However, it is intriguing that the DC subset with the greatest tolerogenic potential also expresses proinflammatory IL12 and IL15 and drives T H 1 cell responses to intestinal infections 166, 167 . This DC subset also expresses Tlr9, which binds bacterial and viral DNA, and triggers signalling cascades that lead to a proinflammatory cytokine response 146 (Fig. 3) .
Intestinal inflammation abrogates the ability of CD103 + DCs to promote pT reg cell differentiation 168 , and under tissue distress, such as dermal parasitic Leishmania major infection, the CD103 + CD11b -DC subset was shown to produce IL12 and to drive T H 1 cell immunity in mice 166 . Similarly, fungal infec tion with Encephalitozoon cuniculi induced a pro inflammatory programme in lamina propriaresiding, IL12producing CD103 
CD11b
-DCs, which drove T H 1 cell responses to the dietary antigen gluten in an IRF1dependent manner in animal models. Interestingly, this study also suggests that whereas IRF1 is required to induce T H 1 cell responses to dietary antigens, it is not required for blocking the pT reg cell induction that requires type I interferon.
Reovirus-mediated inflammatory T helper 1 cell response to dietary antigens. Some of the hypoth eses of an infectious aetiology of coeliac disease include a reovirustriggered induction of proinflammatory type I interferon 83, 170 or virusmediated upregulation and release of the enzyme tissue transglutaminase 171 . In a 2017 study 5 , these associations were moved towards causality, and as a consequence of virus-host inter actions, the pT reg cell response was abrogated, and a patho genic T H 1 cell response to gluten was induced instead.
Importantly, two reovirus strains belonging to the same family of Reoviridae had different capacities to induce LOT, suggesting that particular viral genes interacting with the host can induce signalling pathways that lead to LOT. Intriguingly, other findings (B.J., unpublished observations) suggest that certain viruses, other than reovirus, can also induce LOT through manipulation of tolerogenic DCs presenting dietary antigens. These findings suggest that studying the viral genes that corre late with LOT by generating viral reassortants or mutants will help to understand the underlying mechanisms and to target specific pathways. Mechanistically, T1L reovirus induced LOT by blocking pT reg cell induction through type I interferonmediated pathways. By contrast, T H 
-DCs that express retinal dehydrogenase 2 (RALDH2) and produce retinoic acid (RA) and that migrate to the mesenteric lymph nodes to promote the differentiation of naive CD4 + T cells into peripherally derived forkhead box protein P3 (FOXP3) + regulator T (T reg ) cells (pT reg cells) via a transforming growth factor-β (TGFβ)-dependent and RA-dependent mechanism. In the lamina propria, tolerogenic pT reg cells suppress the inflammatory T cell response and mediate oral tolerance. Enteric pathogenic infections and dysbiosis can alter IEC barrier disruption, leading to uncontrolled translocation of dietary antigens, certain pathogens and pathogen-associated molecular patterns into the intestinal mucosa. Coeliac disease is characterized by a T helper 1 (T H 1) cell response to gluten that leads to IEC destruction and villous atrophy. T H 1 cell responses in coeliac disease are linked to the differentiation of IL-12-producing and possibly IL-27-producing DCs. Most patients with coeliac disease display upregulation of pro-inflammatory IL-15, which can synergize with RA to induce DCs and promote T H 1 cell responses that then instruct plasma cells to produce anti-gluten and anti-transglutaminase 2 (TGase2) antibodies. Type 1 strain Lang (T1L) reovirus infection induces pro-inflammatory CD103 +
-DCs that produce IL-12 via interferon regulatory factor 1 (IRF1) and block the differentiation of pT reg cells. Food allergy is mediated by T H 2 cell responses to dietary antigens. IECs that produce thymic stromal lymphopoietin (TSLP) and IL-33, and tuft cells that produce IL-25, could contribute to food allergy by promoting differentiation of small intestinal CD103 +
+ DCs. Together with IgE-producing plasma cells, IL-4-producing basophils and the IgE-mediated degranulation of mast cells, these processes drive T H 2 cell immunity and consequently food allergy to dietary antigens. Microbial infections inducing IL-4, IL-5 and IL-13 could also contribute to promoting T H 2 cell responses to dietary antigens; however, the mechanisms remain to be defined. IL-13R , IL-13 receptor ; IL-25R , IL-25 receptor (also known as IL-17RB); IL-33R , IL-33 receptor (also known as IL-1RL1); IL-4R , IL-4 receptor ; MHC, major histocompatibility complex; TSLPR , TSLP protein receptor (also known as CRLF2).
factor IRF1 in the CD103 + CD11b
-DCs that present oral antigen and produce IL12 upon T1L reovirus infection. Furthermore, patients with coeliac disease had substan tially higher antireovirus antibody titres than patients without coeliac disease, and intestinal mucosal IRF1 expression levels of patients with coeliac disease were associated with antireovirus antibody titres 5 , suggest ing that antecedent virus-host interactions can initiate longlasting changes in immune homeostasis associated with high mucosal IRF1 expression.
Future studies need to elucidate whether other enteropathogens, besides T1L reovirus, can induce a proinflammatory programme in CD103 +
-DCs, thereby suppressing a tolerogenic pT reg cell response and instead driving a T H 1 cell response that leads to LOT to food antigens 5 and whether this process could have important implications in other food sensitivities 172 . . These findings are relevant to coeliac disease 173 , in which polymorphisms in the gene encoding IL12 are suggested to be a genetic risk factor [175] [176] [177] and in which IL15 upregulation in the lamina propria [178] [179] [180] is associ ated with an upregulation of IL12 (reF.
106
) according to experimental evidence.
In summary, multiple factors have to be considered to define the exact underlying mechanisms of how enteric virus or bacterial infections affect CD103 +
CD11b
-DCs, other DC subsets and mucosal myeloid cells, such as by altering the RALDH2 activity of CD103 + CD11b -DCs, suppressing the tolerogenic programme or inducing a transcription factor that regulates the proinflammatory programme in these cells.
Mechanisms in T helper 2 cell-mediated food allergy.
The stimulation of IECs by pathogens (such as hel minths) and PAMPs (such as bacterial TLR2 ligands) results in the production of thymic stromal lympho poietin (TSLP), IL25 and IL33, which consequently disrupts barrier integrity and leads to T H 2 cell immu nity 181, 182 (Fig. 3) . A population of small intestinal CD103 + CD11b + DCs were shown to mediate mucosal T H 2 cell responses against parasites in mice, and it was also shown that IRF4 is involved and dependent on the type of microbial trigger 183 . Indications exist that certain helminth infections such as those with Heligmosomoides polygyrus can suppress food allergy via a mechanism requiring IL10 that in a dominant manner can suppress T H 2 cell responses 184, 185 ; however, precise mechanisms are lacking. In general, the helminthelicited T H 2 cell response is characterized by high levels of systemic helminthinduced IgE and IgG1 (reF.
186
) and by the prod uction of a series of inflammatory mediators, such as histamine and cytokines (including IL4, IL13, IL6 and TNF), which are released from degranulating mast cells and can further impair intestinal barrier function 139 . Accordingly, Candida albicans colonization was shown to promote gastrointestinal permeation of oral antigens, which was in part mediated by mucosal infiltration and degranulation of mast cells in mice 187 . Future studies are required to clearly define the microbialtriggered T H 2 cell immune response that leads to food allergy.
Conclusions
Development of immune tolerance to dietary antigens is key for homeostatic intestinal and systemic immune responses. Investigations on the role of microbial deter minants in preventing or leading to hypersensitivity reactions to innocuous dietary antigens have been intensively performed during the past two decades. Depletion of protective bacterial strains from the gut microbiota with beneficial metabolic function or the presence of viral infections or bacterial opportunistic pathogens could affect the risk of developing food sen sitivities through a variety of mechanisms. Genetic pre disposition will probably influence the manner in which the host responds to these environmental pressures. The best understood mechanisms involve indirect effects by bacterial metabolites and modification of antigenicity of dietary substrates and direct host effects that impair T reg cell responses or imprint a proinflammatory pro gramme in the host. Although there is currently great emphasis on dietary modulation of the gut microbiota to improve health, this area requires more mechanistic evidence (box 1). Deep knowledge of specific micro organism-diet interactions and their underlying mol ecular pathways will be necessary to develop prevention and novel therapies to treat food sensitivities.
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Box 1 | Outstanding questions in food sensitivities
• The identity of specific food triggers and the underlying mechanisms and biomarkers involved in the context of self-reported adverse food reactions in patients with functional gut disorders remain unclear.
• It is unknown whether intestinal dysbiosis in patients with food sensitivity is the consequence of ongoing (food-induced) inflammation or a post-infectious adverse effect that has a causal role in the breakdown of tolerance to antigen or allergen.
• It remains to be determined whether infections and increased gluten intake synergize to promote breakdown of tolerance to gluten in genetically susceptible people and whether there is a window of opportunity for this effect.
• The mechanisms underlying the paradoxically protective effect of certain helminths in food allergy remain unclear.
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